Talk:Ventricular assist device

message: This article clearly shows the need to include dates that are relevant to statements - for instance the paragraph about the oldest surviving patient has been in the article for over a year and cannot still be true - either he has survived longer than the paragraph suggests or he is now dead.  Similar comments can be made about other paragraphs which include phrases such as "Recently entered Clinical Trials."
The article also needs a lot more citations than it currently has.
I plead guilty to offences on both counts and will attempt to fix my contributions.
Majurawombat 04:06, 20 June 2007 (UTC)
thread_title: Dates and citations

message: I thought that studies were indicating that pulseless pumps i.e centrifugal pumps increased hardening of the arteries and other ailments related to high blood pressure.  My professor (whom works at the UofL hospital) indicated this during an introductory lecture for heart assist devices.
Dr. Mouth 03:22, 9 November 2006 (UTC)
thread_title: Questions

message: http://news.bbc.co.uk/1/hi/health/206667.stm 21 year old Julie Mills had an AB-180 implanted for 6 days in 1998 after a virus infected her heart and shut it down. Reader's Digest also ran an article on this pump. I recall it uses hydrodynamic rotor suspension, using water with a small amount of heparin added.
http://ats.ctsnetjournals.org/cgi/content/abstract/68/2/768  —Preceding unsigned comment added by Bizzybody (talk • contribs) 09:37, 27 March 2008 (UTC)
thread_title: AB-180

message: The "retrospective cohort study" paragraph is repeated word for word in both the "REMATCH" and the "Complications and side effects" sections of this article. However, The version in the second mentioned paragraph contains several useful cross-links. I happened to reference this article by chance, and do not have the detailed knowledge to decide positively which should remain, but it seems to me that the links should be transferred to the "REMATCH" paragraph, and the "Complications" & etc.etc., paragraph should be removed. Would this be correct?--Paraballo (talk) 00:57, 13 October 2009 (UTC)
thread_title: duplicate paragraph

message: I have found a reference, that discusses the generations and their "meanings" in a scientific paper. It is a review concerning VADs.
All implantable VADs consist of an inflow cannula connecting the left ventricle to the pump that then connects to an outflow cannula carrying augmented blood flow to the aorta.9 These devices are best categorized by their flow characteristics and mechanism used to augment cardiac output via the pump. A volume displacement pump consists of a chamber that passively fills before a pusher plate compresses the chamber and ejects blood in pulsatile fashion through the outflow conduit. Axial flow (or second generation) devices consist of an impellar (a rotor with helical blades) around a central shaft that propels blood by drawing it into the inflow cannula and out through the outflow along the axis of the impellar. Newer centrifugal flow or third-generation pumps have cone-shaped or cylindrical rotors that drive blood flow using the centrifugal force generated from the center of the rotor to its circumference (Fig 1). Contemporary devices such as the HeartMate II (HMII) (Thoratec Corp, Pleasanton, Calif), DuraHeart (Terumo Heart Inc, Ann Arbor, Mich), Jarvik 2000 (Jarvik Heart Inc, New York, NY), and the Heartware left ventricular assist system (LVAS) (Heartware Inc, Miami Lakes, Fla) use the latter 2 mechanisms to generate continuous flow with reduced pulsatility in the systemic circulation. An important limitation to the current technology includes an external driveline in all devices that connects the pump to the controller and battery pack. Despite this limitation, the HMII is approved by the Food and Drug Administration (FDA) for use as a BTT and DT.
--Nightware86 (talk) 16:13, 16 December 2011 (UTC)
thread_title: Citation for Generations

message: I suggest merging blood pump into ventricular assist device.
As far as I can tell from reading the articles themselves,
they are talking about more-or-less the same devices.
--DavidCary (talk) 16:29, 26 November 2012 (UTC)
thread_title:  merge 

message: Suggest some mention of stem cell therapy here as a means of shortening the bridge to recovery.
Mesoblast has been very active in this area, with multiple peer reviewed articles on this,
on this page:
http://www.mesoblast.com/science/scientific-publications/cardiac-and-vascular  
One reference describes a clinical trial with LVAD with quite impressive results , and some of the other papers are interesting too 
Salbayeng (talk) 06:13, 22 February 2016 (UTC)
thread_title:  Studies and Outcomes 

message: See http://www.healthcare-in-europe.com/en/article/709.html
81.240.73.229 (talk) 10:11, 6 August 2016 (UTC)
replies: text: Hi, that article is 10 years old -- it's even more outdated than this current version of the Wikipedia article is. Softlavender (talk) 23:46, 8 August 2016 (UTC)
replies: text:  Yes, but some devices weren't in the list. These are:
* WorldHeart Rotary VAD
* EvaHeart
* Impella CardioSystems GmbH
* Centrimag/Levitronix AG
* Circulite Inc
* Heart Turcica Centrifugal
Please add to article list  
Also, are there any devices that have the batteries inside the body as well (similar to pacemakers, ...)
see http://www.medscape.com/viewarticle/758065
— Preceding unsigned comment added by 81.240.73.229 (talk) 07:31, 9 August 2016 (UTC)
thread_title: Extra devices for list

message: doi:10.1161/CIR.0000000000000507 JFW | T@lk 09:40, 21 June 2017 (UTC)
thread_title:  Ambulatory and community care 

message: — Assignment last updated by DLEMERGEBM (talk) 21:37, 9 November 2023 (UTC)
thread_title: Wiki Education assignment: WikiProject Medicine Fall 2023 UCF COM